Clinical Trial Update: Accessing Peripheral Occluded LesiOns II (APOLO-II) [Phase 3]

View source ↗

Summary

The APOLO-II Phase 3 trial evaluating treatment for femoropopliteal occlusive disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Femoropopliteal Occlusive Disease

Snippet

Sponsor: EndoCross Ltd. | Conditions: Femoropopliteal Occlusive Disease | Phase 3 | Status: WITHDRAWN